Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed synthesis of 1-hydroxy-2,5,8-trimethyl-9-fluorenone from patent CN112574033B offers scalable, cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN110183394B reveals a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering safer cyanation and scalable manufacturing for global supply chains.
Novel strained-ring phosphine catalysts from patent CN108250239B enable efficient intramolecular Wittig reactions with high yields and simplified purification for API synthesis.
Patent CN111217844A details a zirconium-catalyzed 1,1-diboronation method. This breakthrough offers cost reduction in fine chemical manufacturing and high-purity organoboron intermediates.
Advanced process for high-purity ondansetron synthesis reducing exo-methylene impurities. Cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN111393333B details a green aqueous silver-catalyzed dearomatization method. This breakthrough offers high regioselectivity and scalable production for pharmaceutical intermediates.
Patent CN115215895A details a cost-effective ruthenium-catalyzed synthesis of five-membered silicon-containing fused heterocycles, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN113801859A details high-efficiency carbonyl reductase mutants for chiral alcohol synthesis, offering superior stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN103497082A reveals a solvent-free Henry reaction using ethanolamine-based ionic liquids, offering high yields and catalyst reusability for reliable pharma intermediate supply chains.
Novel patent CN111574380B details efficient reductive coupling for high-purity diaminobiphenyls, offering cost reduction and scalable supply for polymer and pharma sectors.
Novel double dearomatization method for spiro-indolizidines. High yield up to 95%. Cost-effective route for API intermediates without precious metals.
Novel amino acid-catalyzed route in ionic liquids offers green, high-yield production of alpha-acyl substituted esters for pharmaceutical manufacturing.
Patent CN111217848A details novel silicon-centered spiro ligands enabling high-yield asymmetric synthesis. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114262290B reveals silver-catalyzed synthesis for high-purity heterocyclic compounds. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN107011134B reveals a streamlined lithiation-acetylation route for 2-fluoro-5-bromoacetophenone, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.